PMID- 35773566 OWN - NLM STAT- MEDLINE DCOM- 20220704 LR - 20220711 IS - 1432-072X (Electronic) IS - 0302-8933 (Linking) VI - 204 IP - 7 DP - 2022 Jun 30 TI - Modulatory apoptotic effects of sinomenine on Mycoplasma pneumonia through the attenuation of inflammation via ERK/JNK/NF-kappaB signaling pathway. PG - 441 LID - 10.1007/s00203-022-03039-w [doi] AB - Mycoplasma pneumoniae (MPP) induced pneumonia is a common disease of children. Sinomenine (SIN) is an isoquinoline mainly sequestered from Sinomenium acutum. It is a promising drug for treating arthritis, lung, colon, liver and gastric cancer. Hence, the present study investigated the role and mechanism of SIN treatment in MPP induced pneumonia in experimental in-vivo mice model. The BALB/c male mice were separated into four groups (n = 6 mice/group): normal, MPP, MPP + SIN (20 mg/kg bw), and SIN (20 mg/kg bw) alone. Results were expressed as mean +/- SD. Data were analyzed using one way Analysis of Variance (ANOVA) with the Dunnett's post hoc test using SPSS v 18.0. P value < 0.05 was considered significant. The total protein, cell count, inflammatory cytokines, MP-IgM, Monocyte chemo attractant protein-1 (MCP-1), and MP-DNA were measured. The protein expressions of Bax/Bcl-2, ERK, JNK, NF-kappaB were analyzed and histopathology of lungs was examined. SIN treatment significantly (p < 0.05) reduced the total proteins, cell counts in BALF, inflammatory cytokines, MP-IgM, MCP-1, MP-DNA and reversed the histological alterations. SIN attenuated the apoptotic pathway through the modulation of Bax/Bcl-2 expression. SIN alleviated pulmonary inflammatory mediators and apoptosis in MPP-infected mice via suppression of ERK/JNK/NF-kappaB signaling. SIN administration diminished inflammation and lung fibrosis by inhibiting apoptosis in MPP mice. Hence, SIN is a potential natural protective remedy for MPP. CI - (c) 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Chen, Yao AU - Chen Y AD - Department of Respiratory, Xi'an Children's Hospital, Xi'an City, 710000, China. FAU - Zhang, Wen AU - Zhang W AD - Department of Respiratory, Xi'an Children's Hospital, Xi'an City, 710000, China. FAU - Xin, Lihong AU - Xin L AD - Department of Respiratory, Xi'an Children's Hospital, Xi'an City, 710000, China. FAU - Wang, Zhen AU - Wang Z AD - Department of Respiratory, Xi'an Children's Hospital, Xi'an City, 710000, China. FAU - Zheng, Mao AU - Zheng M AUID- ORCID: 0000-0002-2436-8956 AD - Department of Emergency, Xi'an Children's Hospital, Xi'an City, 710000, China. zhengmao19810908@sina.com. FAU - Vijayalakshmi, Annamalai AU - Vijayalakshmi A AD - Department of Biochemistry, Rabiammal Ahamed Maideen College for Women, Thiruvarur, Tamil Nadu, 610001, India. LA - eng PT - Journal Article DEP - 20220630 PL - Germany TA - Arch Microbiol JT - Archives of microbiology JID - 0410427 RN - 0 (Cytokines) RN - 0 (Immunoglobulin M) RN - 0 (Morphinans) RN - 0 (NF-kappa B) RN - 0 (bcl-2-Associated X Protein) RN - 63LT81K70N (sinomenine) SB - IM MH - Animals MH - Cytokines/metabolism MH - Immunoglobulin M MH - Inflammation MH - *MAP Kinase Signaling System/drug effects MH - Male MH - Mice MH - Mice, Inbred BALB C MH - *Morphinans/pharmacology MH - *Mycoplasma pneumoniae/drug effects MH - *NF-kappa B/metabolism MH - *Pneumonia, Mycoplasma/drug therapy/metabolism MH - bcl-2-Associated X Protein/metabolism OTO - NOTNLM OT - Apoptosis OT - Mycoplasma pneumonia OT - NF-kappaB OT - Sinomenine OT - cytokines OT - inflammation EDAT- 2022/07/01 06:00 MHDA- 2022/07/06 06:00 CRDT- 2022/06/30 23:34 PHST- 2022/02/01 00:00 [received] PHST- 2022/06/01 00:00 [accepted] PHST- 2022/06/30 23:34 [entrez] PHST- 2022/07/01 06:00 [pubmed] PHST- 2022/07/06 06:00 [medline] AID - 10.1007/s00203-022-03039-w [pii] AID - 10.1007/s00203-022-03039-w [doi] PST - epublish SO - Arch Microbiol. 2022 Jun 30;204(7):441. doi: 10.1007/s00203-022-03039-w.